Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04153513Phase 2Completed
Phase 2, randomised, open-label trial of lanolin in nipple pain and cracked nipple (2 arms), sponsored by University of Mostar. Primary endpoints: Nipple pain severity at 7 days and Nipple trauma score at 7 days. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04153513.